Search results
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
Investor's Business Daily· 6 months agoAbbVie has agreed to buy ImmunoGen for $10.1 billion in cash, offering a rich premium for the maker...
Federal government to penalize North Chicago-based AbbVie over the price of its blockbuster drug...
Chicago Tribune via Yahoo News· 1 year agoNorth Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the federal government said Wednesday. The penalty follows years ...
North Chicago-based AbbVie’s revenue tumbles as its blockbuster drug Humira faces competition
Chicago Tribune via Yahoo News· 1 year agoRevenue at North Chicago-based AbbVie dove by nearly 10% during the first few months of this year — a drop that comes as its bestselling drug Humira faces competition for the first time in the ...
AbbVie's $8.7 billion bet on Cerevel is risky but smart, analysts say
Reuters via Yahoo Finance· 6 months agoAbbVie's decision to buy Cerevel Therapeutics before key data on the drug developer's experimental...
Here's How Much You'd Have If You Invested $1000 in AbbVie a Decade Ago
Zacks via Yahoo Finance· 6 months agoHow much a stock's price changes over time is important for most investors, since price performance...
Drugmaker AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio
Associated Press via Yahoo News· 6 months agoAbbVie will pay around $10 billion to add a potential blockbuster cancer treatment as cheaper...
Good news for consumers, bad news for North Chicago-based AbbVie as its blockbuster drug Humira...
Chicago Tribune via Yahoo News· 1 year agoOne of the most popular prescription medications in the world is about to face fierce competition in the U.S. — something that could mean lower prices for the drug but a difficult coming year ...
Zacks.com featured highlights include Dillard's, Suzano, Atkore, Nexstar Media Group and AbbVie
Zacks via Yahoo Finance· 11 months agoFor Immediate Release Chicago, IL – July 10, 2023 – Stocks in this week’s article are Dillard's,...
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 1 week agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
AbbVie: Q3 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 8 months agoNORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday reported third-quarter profit of $1.78 billion. The North Chicago, Illinois-based company said it had profit ...